Xu, Guowang

Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention

Liu, R., Hong, J., Xu, X., Feng, Q., Zhang, D., Gu, Y., Shi, J., Zhao, S., Liu, W., Wang, X., et al. (2017) · Nature Medicine

Gut microbiota and healthAdipokines, Inflammation, and Metabolic Diseases

Cited by 1,501

Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)

Zhang, Y., Gu, Y., Ren, H., Wang, S., Zhong, H., Zhao, X., Ma, J., Gu, X., Xue, Y., Huang, S., et al. (2020) · Nature Communications

Berberine and alkaloids researchGut microbiota and health

Cited by 380

Stress-induced epinephrine enhances lactate dehydrogenase A and promotes breast cancer stem-like cells

Cui, B., Luo, Y., Tian, P., Peng, F., Lu, J., Yang, Y., Su, Q., Liu, B., Yu, J., Luo, X., et al. (2019) · Journal of Clinical Investigation

Cancer, Hypoxia, and MetabolismCancer, Stress, Anesthesia, and Immune Response

Cited by 308

Relationship of Serum Trimethylamine N-Oxide (TMAO) Levels with early Atherosclerosis in Humans

Randrianarisoa, E., Lehn-Stefan, A., Wang, X., Hoene, M., Peter, A., Heinzmann, S. S., Zhao, X., Königsrainer, I., Königsrainer, A., Balletshofer, B., et al. (2016) · Scientific Reports

Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Health and Disease Prevention

Cited by 296

Comprehensive metabolic profiling of Parkinson’s disease by liquid chromatography-mass spectrometry

Shao, Y., Li, T., Liu, Z., Wang, X., Xu, X., Li, S., Xu, G., & Le, W. (2021) · Molecular Neurodegeneration

Metabolomics and Mass Spectrometry StudiesParkinson's Disease Mechanisms and Treatments

Cited by 226

Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at?

Zhao, X., Peter, A., Fritsche, J., Elcnerova, M., Fritsche, A., Häring, H.-U., Schleicher, E. D., Xu, G., & Lehmann, R. (2009) · American Journal of Physiology-Endocrinology and Metabolism

Metabolomics and Mass Spectrometry StudiesDiet, Metabolism, and Disease

Cited by 170

Plasma lipidomics reveals potential lipid markers of major depressive disorder

Liu, X., Li, J., Zheng, P., Zhao, X., Zhou, C., Hu, C., Hou, X., Wang, H., Xie, P., & Xu, G. (2016) · Analytical and Bioanalytical Chemistry

Metabolomics and Mass Spectrometry StudiesTreatment of Major Depression

Cited by 148

Exercise-induced secretion of FGF21 and follistatin are blocked by pancreatic clamp and impaired in type 2 diabetes

Hansen, J. S., Pedersen, B. K., Xu, G., Lehmann, R., Weigert, C., & Plomgaard, P. (2016) · The Journal of Clinical Endocrinology & Metabolism

Fibroblast Growth Factor ResearchAdipokines, Inflammation, and Metabolic Diseases

Cited by 106

Current and future perspectives of functional metabolomics in disease studies–A review

Yan, M., & Xu, G. (2018) · Analytica Chimica Acta

Metabolomics and Mass Spectrometry StudiesBioinformatics and Genomic Networks

Cited by 105

Analysis of Artemisia annua L. volatile oil by comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry

Ma, C., Wang, H., Lu, X., Li, H., Liu, B., & Xu, G. (2007) · Journal of Chromatography A

Essential Oils and Antimicrobial ActivityPlant chemical constituents analysis

Cited by 80

Terpenoid metabolic profiling analysis of transgenic Artemisia annua L. by comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry

Ma, C., Wang, H., Lu, X., Wang, H., Xu, G., & Liu, B. (2009) · Metabolomics

Plant biochemistry and biosynthesisPlant tissue culture and regeneration

Cited by 76

Alteration of Lipids and Amino Acids in Plasma Distinguish Schizophrenia Patients from Controls: A Targeted Metabolomics Study

Liu, Y., Song, X., Liu, X., Pu, J., Gui, S., Xu, S., Tian, L., Zhong, X., Zhao, L., Wang, H., et al. (2021) · Psychiatry and Clinical Neurosciences

Metabolomics and Mass Spectrometry StudiesSchizophrenia research and treatment

Cited by 48